Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.

Journal of cellular biochemistry - 1 Nov 2015

Warren Julia T, Zou Wei, Decker Corinne E, Rohatgi Nidhi, Nelson Christopher A, Fremont Daved H, Teitelbaum Steven L

Abstract excerpt

The interaction between Receptor Activator of NF-κB Ligand (RANKL) and its receptor RANK is essential for the differentiation and bone resorbing capacity of the osteoclast. Osteoprotegerin (OPG), a soluble homodimer, acts as a decoy receptor for RANKL and thus inhibits osteoclastogenesis. An imba...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Kinetics
Share to Macrophages

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Osteoclasts

Share to Osteoprotegerin

Share to RANK Ligand

Share to Receptor Activator of Nuclear Factor-kappa B

Share to Recombinant Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 25864714
DOI: 10.1002/jcb.25191
PMCID: PMC4581524

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25864714-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.PMID 25864714Read ↗

Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand.Semantic proximity Read ↗

Historically significant events in the discovery of RANK/RANKL/OPGSemantic proximity Read ↗

Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.Semantic proximity Read ↗

Role of RANKL Signaling in Bone HomeostasisSemantic proximity Read ↗

New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.Semantic proximity Read ↗

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL.Semantic proximity Read ↗

A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.Semantic proximity Read ↗

Novel RANKL DE-loop mutants antagonize RANK-mediated osteoclastogenesis.Semantic proximity Read ↗

The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.Semantic proximity Read ↗

RANKL and RANK: From Mammalian Physiology to Cancer Treatment.Semantic proximity Read ↗

Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesisSemantic proximity Read ↗

Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.